Skip to main content
. 2010 Jan 27;285(13):9813–9822. doi: 10.1074/jbc.M109.091496

FIGURE 4.

FIGURE 4.

ChIP assays indicate that E2F1 and CDKN1C coexist in complexes on the E2F1, E2F3, and cyclin A2 promoters. A, H1299 cells were treated with either Ad-GFP or Ad-p57 for 48 h as indicated. Quantitative ChIP assays were performed on the E2F1, E2F3, and cyclin A2 promoters using antibodies as indicated on the x-axis. “IgG” represents a negative control (Santa Cruz Biotechnology, sc-1027). E2F1 represents E2F1 antibody (Santa Cruz Biotechnology, sc-193). “P57” represents CDKN1C antibody (Santa Cruz Biotechnology, sc-1040). Results were normalized to % total recovery from the input chromatin. B, quantitative ChIP assays on the E2F3 promoter were performed using antibodies against various RNA pol II phospho-isoforms. Additionally, in this experiment results were normalized to relative occupancy over the occupancy of the myoglobin B intron.